SNY:NASDAQ
Sanofi SA
USD 40,20
arrow_upward
+1,62%(+0,64) 1D
USD 40,20
0,00% (0,00)
bedtimeAfter hours
Closed: 7 Okt., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SNY...
Open
USD 39,94
High
USD 40,25
Low
USD 39,72
Mkt. cap
97,24 mjd
Avg. vol.
2,69 m
Volume
0,00
Dividend
6,02%
Quarterly dividend
USD 0,60
Ex-dividend date
05 Mei 2026
P/E ratio
21,90
52-wk high
USD 52,68
52-wk low
USD 39,18
EPS
USD 1,84
Beta
0,37
Shares outstanding
2,42 mjd
No. of employees
75 k
Open
USD 39,94
High
USD 40,25
Low
USD 39,72
Mkt. cap
97,24 mjd
Avg. vol.
2,69 m
Volume
0,00
Dividend
6,02%
Quarterly dividend
USD 0,60
Ex-dividend date
05 Mei 2026
P/E ratio
21,90
52-wk high
USD 52,68
52-wk low
USD 39,18
EPS
USD 1,84
Beta
0,37
Shares outstanding
2,42 mjd
No. of employees
75 k
News stories
From web sources and news partners
AD HOC NEWS
·
17 uur gelede
Sanofi stock gains 1.02 percent as antibody deal advances pipeline
AD HOC NEWS
·
22 uur gelede
Sanofi expands Regeneron alliance: what it means for Sanofi stock
TipRanks
·
1 dag gelede
Regeneron, Sanofi deepen antibody collaboration with expanded alliance
AD HOC NEWS
·
1 dag gelede
Argus upgrades Regeneron stock to Buy with USD 850.00 target
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOPaul Hudson | Belén Garijo
Employees74,8 k
Founded1973
HeadquartersParys, Île-de-France, Frankryk
SectorPharmaceutical industry
Websitesanofi.com